Latest Breaking News On - Novel autotaxin inhibitor - Page 1 : comparemela.com

The phase 3 clinical trials evaluating ziritaxestat for treating idiopathic pulmonary fibrosis showed no improvement in clinical outcomes leading to the termination of the trials due to lack of efficacy.

City ofUnited kingdomToby maherUniversity of southern californiaImperial college londonLung instituteKeck school of medicineNational heartKeck schoolSouthern californiaTreatment optionsRespiratory questionnaireNovel autotaxin inhibitorLung functionIdiopathic pulmonary fibrosis